Fighting For Her Life with a Clinical trial

By Cody R. Barnett, MRA Director of Communications | 7 June 2019 In Melanoma Stories, Science, Treatment

Colleen Wittoesch was a regular volunteer at MD Anderson Cancer Center. She came to the hospital every week to help out and spend time with patients and families in the melanoma clinic for going on seven years. Little did she know that in 2016 she too would walk through the clinic doors as a patient.

Read More


Highlights from the 2019 Scientific Retreat

30 May 2019 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment

Over the course of three days, MRA convened over 300 people from across the melanoma research community: patients, doctors, researchers, industry, and government. Participants discussed everything from new treatment approaches such as RNA-based vaccines, strategies to fight back against treatment resistance, and hurdles to testing neo-adjuvant therapies in melanoma.

Read More


Clinical Trials to Watch: Turning Cold Tumors Hot

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 15 May 2019 In Science, Treatment

We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?

Read More


Police Lieutenant Tackles Melanoma in Phoenix

By Charles Brodine, MRA Intern | 13 May 2019 In Melanoma Stories, Prevention

After being diagnosed with Stage 3 melanoma, Chris Eyrich is committed to raising awareness about melanoma. He works to raise awareness of the unique occupational hazards faced by people who work primarily outdoors, such as police officers and other public servants.

Read More


Join MRA to Find Inspiration and Hope Through the Power of Storytelling with the Newly Launched With Love, Me Program.

9 May 2019 In Allies & Partnerships

This year, we’re continuing our partnership with Merck to help those impacted by melanoma with the launch of a new program – With Love, Me. The new initiative features heartfelt letters written by caregivers and cancer survivors to their newly diagnosed selves and other caregivers touching upon what they wish they had known when they were first diagnosed/providing care.

Read More


Research is Hope: MRA Announces $8.2 Million for New Grant Awards to Advance Melanoma Research

By Cody R. Barnett, MRA Director of Communications | 30 April 2019 In News, Science

In advance of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today announced funding for 33 innovative research awards totaling $8.26 million.

Read More


Double Your Impact: May Fundraisers Matched Dollar-For-Dollar!

By Cody R. Barnett, MRA Director of Communications | 18 April 2019 In Allies & Partnerships, News

Thanks to a generous matching gift from our co-founders, Debra and Leon Black, every donation made to MRA through an individual fundraising campaign in May, will be matched dollar-for-dollar, up to $65,000.*

Read More


Building Community While Raising More than $10 Million for Melanoma

By Cody R. Barnett, MRA Director of Communications | 15 April 2019 In Allies & Partnerships, Events

Leveraged Finance Fights Melanoma has become an annual event that brings over 1,000 people together from the leveraged finance and private equity community. Cofounder Brendan Dillon shares his own journey with melanoma.

Read More


Melanoma Vaccines Show Promise

14 April 2019 In Science, Treatment

While immunotherapy has transformed way melanoma is treated, about half of patients still do not respond. Researchers are pursuing multiple strategies to understand why this happens and to develop strategies to jumpstart a response. One approach showing promise in early clinical trials, comes in the form of new personalized vaccines being developed by Ugur Sahin of Johannes Gutenberg-Universität Mainz and BioNTech.

Read More


What’s Next for the Microbiome in Melanoma?

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 11 April 2019 In Science, Treatment

We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?

Read More


Login

×